Histogen Inc. (HSTO) Financial Statements (2026 and earlier)

Company Profile

Business Address 10655 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:12,10918,6856,76320,70340,70074,900
Cash and cash equivalent12,10918,6856,76320,70311,56516,079
Other undisclosed cash, cash equivalents, and short-term investments     29,13558,821
Restricted cash and investments40040010   
Receivables 99165144   
Inventory, net of allowances, customer advances and progress billings  61300   
Inventory  61300   
Prepaid expense707823745   
Other current assets77183319   
Other undisclosed current assets641,2921199036,7264,324
Total current assets:13,45621,6098,40021,60647,42679,224
Noncurrent Assets
Operating lease, right-of-use asset 4,6584,4324,411 ✕✕
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization 436399271 154179
Other noncurrent assets5238051,9312211,2232,538
Total noncurrent assets:5,6175,6366,6132211,3772,717
TOTAL ASSETS:19,07327,24515,01321,82748,80381,941
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:9772,1842,4191,0646,21611,962
Employee-related liabilities✕✕  2382,2302,008
Accounts payable3821,393539   
Accrued liabilities5957911,880   
Other undisclosed accounts payable and accrued liabilities    8263,9869,954
Deferred revenue191948 ✕✕
Debt   97338  
Deferred revenue and credits✕✕✕✕✕✕14,172
Contract with customer, liability✕✕✕✕✕10,075✕
Other undisclosed current liabilities 2381272212382,2302,008
Total current liabilities:1,2342,3302,7851,64018,52128,142
Noncurrent Liabilities
Long-term debt and lease obligation 54,6314,806  13,158
Long-term debt, excluding current maturities      13,158
Finance lease, liability 514  ✕✕
Liabilities, other than long-term debt4,45898140 2,88312,645
Deferred revenue and credits✕✕✕✕✕✕12,645
Deferred revenue7998118 ✕✕
Contract with customer, liability✕✕✕✕✕2,815✕
Deferred rent credit     68✕
Other liabilities   22   
Operating lease, liability 4,3794,6174,806 ✕✕
Other undisclosed noncurrent liabilities   369   
Total noncurrent liabilities:4,4634,7295,315 2,88325,802
Total liabilities:5,6977,0598,1001,64021,40453,945
Equity
Equity, attributable to parent14,40521,1927,86020,18727,39927,996
Common stock551333
Additional paid in capital102,67398,83970,561218,198214,042196,077
Accumulated other comprehensive loss     (17)(77)
Accumulated deficit(88,273)(77,652)(62,702)(198,014)(186,629)(168,007)
Equity, attributable to noncontrolling interest(1,029)(1,006)(947)   
Total equity:13,37620,1866,91320,18727,39927,996
TOTAL LIABILITIES AND EQUITY:19,07327,24515,01321,82748,80381,941

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues3,7691,0322,05921,71733,58635,377
Cost of revenue
(Cost of Product and Service Sold)		 (61) (202)   
Other undisclosed gross profit      
Gross profit:3,7081,0321,85721,71733,58635,377
Operating expenses(14,412)(16,489)(20,917)(33,723)(51,863)(52,927)
Other undisclosed operating income61 202   
Operating loss:(10,643)(15,457)(18,858)(12,006)(18,277)(17,550)
Nonoperating income (expense)(1)44841621267154
Investment income, nonoperating(1)(10)(64)568962892
Other nonoperating income (expense) 458105531(76)
Interest and debt expense (1)(3)(3) (696)(662)
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations:(10,645)(15,012)(18,820)(11,385)(18,706)(18,059)
Loss before gain (loss) on sale of properties:✕✕(15,012)(18,820)(11,385)(18,706)(18,059)
Other undisclosed net income (loss)133 696 
Net loss:(10,644)(15,009)(18,817)(11,385)(18,010)(18,059)
Net income attributable to noncontrolling interest235948   
Other undisclosed net income attributable to parent      662
Net loss attributable to parent:(10,621)(14,950)(18,769)(11,385)(18,010)(17,396)
Preferred stock dividends and other adjustments (488)     
Net loss available to common stockholders, diluted:(11,109)(14,950)(18,769)(11,385)(18,010)(17,396)

Comprehensive Income ($ in thousands)
Annual | Quarterly

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(10,644)(15,009)(18,817)(11,385)(18,010)(18,059)
Comprehensive loss:(10,644)(15,009)(18,817)(11,385)(18,010)(18,059)
Comprehensive income, net of tax, attributable to noncontrolling interest235948   
Other undisclosed comprehensive income, net of tax, attributable to parent    1760591
Comprehensive loss, net of tax, attributable to parent:(10,621)(14,950)(18,769)(11,368)(17,950)(17,467)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: